BGXX Bright Green Corp Quarterly EPS earnings growth

Graphic logo of Bright Green (BGXX)

By outsourcing greenhouse construction to external contractors, Bright Green focuses on agrotechnology, as evidenced by quarterly growth in net income per share, where the current status is 54.80. The company is implementing AI climate control and robotic harvesting to reduce costs. Attracting leading biologists through stock option programs ensures scientific progress within the legal US sector.

brightgreen.us (BGXX) Year-over-year earnings per one share growth for the last 12 months: for the period 04/28/2023 - 09/21/2024

Metric breakdowns and analytics for brightgreen.us (BGXX)

- market value and analyst target forecast:
Summary company analytics:Bright Green Corp., BGXX
Flagship merchandise of Bright Green

The indicator measures the rate of change in quarterly earnings per share, filtering out market noise through a daily recalculation of reporting data to identify the true trajectory of profitability. Analyzing quarterly EPS variability allows for an assessment of how the unique licensing status of Bright Green (BGXX) within the medical cannabis sector converts into actual financial growth and pricing power over pharmaceutical raw materials.

Competitor analysis for Bright Green

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|NTRB: Quarterly EPS earnings growth|NSRX - Year-over-year net earnings per share change for the last twelve months|IGC (IGC Pharma Inc) - Quarterly EPS earnings growth|MIRA Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth FLGC|IM Cannabis - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ADIL (Adial Pharmaceuticals)|Artelo - Year-over-year earnings per share growth for the last twelve months|ensysce.com - Quarterly EPS earnings growth|TTNP - Quarterly EPS earnings growth|GNLN (Greenlane Holdings) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months InMed Pharmaceuticals|Year-over-year earnings per share growth for the last twelve months Akanda Corporation|Earnings per share growth in annualized terms for the last twelve months Enveric Biosciences Inc ENVB|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)